These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 38840097)
1. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma. Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097 [TBL] [Abstract][Full Text] [Related]
2. Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran. Nourmohammadi B; Tafsiri E; Rahimi A; Nourmohammadi Z; Daneshvar Kakhaki A; Cho W; Karimipoor M Asian Pac J Cancer Prev; 2019 Jun; 20(6):1633-1639. PubMed ID: 31244281 [TBL] [Abstract][Full Text] [Related]
3. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma. Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412 [No Abstract] [Full Text] [Related]
4. Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis. Chen H; Lu W; Huang C; Ding K; Xia D; Wu Y; Cai M Oncotarget; 2017 May; 8(19):31435-31448. PubMed ID: 28416756 [TBL] [Abstract][Full Text] [Related]
5. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment. Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689 [TBL] [Abstract][Full Text] [Related]
6. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma. Chen P; Liu H; Hou A; Sun X; Li B; Niu J; Hu L Med Sci Monit; 2018 Feb; 24():1145-1151. PubMed ID: 29476046 [TBL] [Abstract][Full Text] [Related]
8. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma. Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker. Zhang D; Liang P; Xia B; Wu J; Hu X BMC Cancer; 2024 Aug; 24(1):987. PubMed ID: 39123194 [TBL] [Abstract][Full Text] [Related]
10. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma. Xiao H; Tang K; Liu P; Chen K; Hu J; Zeng J; Xiao W; Yu G; Yao W; Zhou H; Li H; Pan Y; Li A; Ye Z; Wang J; Xu H; Huang Q Oncotarget; 2015 Nov; 6(35):38005-15. PubMed ID: 26461224 [TBL] [Abstract][Full Text] [Related]
11. Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing. Zhang X; Zhou J; Wang Y; Wang X; Zhu B; Xing Q Biochem Genet; 2024 Jun; 62(3):1502-1520. PubMed ID: 37642814 [TBL] [Abstract][Full Text] [Related]
12. miR-144-3p inhibited the growth, metastasis and epithelial-mesenchymal transition of colorectal adenocarcinoma by targeting ZEB1/2. Li T; Tang C; Huang Z; Yang L; Dai H; Tang B; Xiao B; Li J; Lei X Aging (Albany NY); 2021 Jul; 13(13):17349-17369. PubMed ID: 34226299 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma. Huang M; Zhang T; Yao ZY; Xing C; Wu Q; Liu YW; Xing XL BMC Med Genomics; 2021 Mar; 14(1):72. PubMed ID: 33750388 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma. Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389 [TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressive roles of ΔNp63β-miR-205 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma via targeting ZEB1 and ZEB2. Hashiguchi Y; Kawano S; Goto Y; Yasuda K; Kaneko N; Sakamoto T; Matsubara R; Jinno T; Maruse Y; Tanaka H; Morioka M; Hattori T; Tanaka S; Kiyoshima T; Nakamura S J Cell Physiol; 2018 Oct; 233(10):6565-6577. PubMed ID: 29150940 [TBL] [Abstract][Full Text] [Related]
17. Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks. Soleymani L; Zarrabi A; Hashemi F; Hashemi F; Zabolian A; Banihashemi SM; Moghadam SS; Hushmandi K; Samarghandian S; Ashrafizadeh M; Khan H Curr Cancer Drug Targets; 2021; 21(9):749-767. PubMed ID: 34077345 [TBL] [Abstract][Full Text] [Related]
18. The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1. Xiang W; Lv L; Zhou G; Wu W; Yuan J; Zhang C; Jiang G Cancer Med; 2020 Jun; 9(12):4251-4264. PubMed ID: 32281285 [TBL] [Abstract][Full Text] [Related]
19. Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma. Yang K; Hu B; Zhu G; Yuan D; Wang W; Su H; Liu H; Zhu J Arch Esp Urol; 2023 Jun; 76(4):270-282. PubMed ID: 37455526 [TBL] [Abstract][Full Text] [Related]
20. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related] [Next] [New Search]